AUCTORES
Globalize your Research
Review | DOI: https://doi.org/10.31579/2640-1053/091
*Corresponding Author: Ahmad Reza Rahnemoon, Retired in Hematology Department, Iran University of Medical Sciences, Tehran, Iran.
Citation: Ahmad Reza Rahnemoon. (2021). ETV6/RUNX1 fusion gene and its active role. J. Cancer Research and Cellular Therapeutics. 5(4);
Doi: 10.31579/2640-1053/091
Copyright: © 2021 Ahmad Reza Rahnemoon, This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Received: 20 July 2021 | Accepted: 06 August 2021 | Published: 16 August 2021
Keywords: ETV6/RUNX1; stem cell; acute lymphoid leukemia; infection
Recent investigation successfully identified a pre leukemic ETV6/RUNX1-positive clone in the healthy twin of a patient diagnosed with ETV6/RUNXI-positive acute lymphoblastic leukemia (ALL) and also some studies with ETV6/RUNX1 knock in mice showed that the expression of the fusion gene is not sufficient for the invivo induction of ALL. Taken together, these data indicate that ETV6/RUNX1-positive leukemia is .generated through a multi-step mechanism, and that accumulation of additional genetic changes is necessary for the development of overt leukemia. Hence, to understand fully the genetic evolution of this disorder, identification of the complete spectrum of genetic changes that accompany the ETV6/RUNX1 fusion gene is necessary. Moreover, critical patho genetic insights may be gained from studying the correlation pattern of the different copy number changes.
What might be responsible for the relatively high frequency (~1%) of ETV6/RUNX1 fusion generation in normal fetal hematopoiesis? Presumably, nonfunctional fusions (in non-stem cells) occur at an even higher rate. One possibility is that these are ‘normal’ developmental errors of DNA maintenance reflecting the complexity of embryo and fetal tissue engineering in which cell death, DNA damage and oxidative stress are ubiquitous [2]. The initiation of other pediatric cancers has similarly been ascribed to developmental accidents [9]. Even if ETV6/RUNX1 fusion is, in effect, a spontaneous error, the risk of this event occurring may be modified by other factors. There is dietary and genetic evidence that folate has an impact on the risk of infant and childhood leukemia, and this could well be operative during pregnancy in utero, influencing the likelihood of chromosomal breaks.
Acute lymphoblastic leukemia (ALL) is defined by recurrent chromosomal aberrations. The vast majority of cases belong to the B cell precursor subtype. Many of these aberrations originate in utero and the cells transform in early childhood. Actually infant ALL with KMT2A rearrangements as well as childhood ALL is caused by a combination of genetic susceptibility factors and also acquired somatic mutations subsequently. The mutations happen in genes generally which are critical for lymphoid development. The first hit of secondary change produces a pre-leukemic state. In fact, it is widely accepted that leukemia with gene fusions can occur before birth. For example, in twins with ETV6/RUNX1, the ALL development can occur at different times, and the postnatal latency can be protracted occasionally and variable too [20, 27].
Some studies indicated that although ETV6/RUNX1 may be linked to early pre leukemia clonal expansion, it is insufficient for overt ALL. First, the protracted postnatal interval, or latency, before disease diagnosis can be up to a decade or more [4] and concordance rates in twins are modest at ~ 10% [1]. This suggests that additional or secondary and complementary genetic events are required. Second, frequency of ‘functional’ ETV6/RUNX1 fusions in normal newborns is ~ 100 × the leukemia rate This interpretation accords with conventional wisdom in two- or multistep models of cancer clone evolution [5] and also fits with results from transgenic modeling with fusion genes. There might not be an exclusive second genetic ‘hit’ but at diagnosis most cases of ALL with ETV6/RUNX1 fusions have deletion of the non-rearranged or normal ETV6 allele. Deletions are sub clonal to ETV6/RUNX1 fusions and are distinct in their genomic boundaries in twins, and in relapse versus diagnostic samples from the same individuals [6]. ETV6 deletions are therefore likely to be postnatal secondary events, albeit a common and integral component of the molecular pathogenesis of cALL. Deletion of normal ETV6 must have some potent selective advantage in cells carrying ETV6/RUNX1 fusions, which might relate either to a suppressor function of ETV6 [7] and/or to the ability of normal ETV6 protein to dimerize with ETV6/RUNX1 and reduce its transforming activity. One intriguing proposal, with therapeutic implications, is that fusion genes encoding hybrid transcription factors such as ETV6/RUNX1 also require genetic complementation with mutant or activated kinases [8] Activated kinases could interfere with the cell cycle and complement the differentiation-blocking activity of chimeric transcription factors. Whether ETV6 deletion itself is sufficient to dys regulate the cell cycle in this way remains to be assessed.
Gene RUNX1 (AML1) or CBFA2 is located in the chromosome band 21q22. Its product makes up a transcription factor as well, that binds the sequence TGT/cGGT. This affinity intensifies consequently hetero dimerization with the CBFβ protein forming a complex called human core-binding factor (CBF). The activity of this complex is critical during the expression of genes specific for hematopoiesis. RUNX1 is normally expressed in all hematopoietic lineages and acts to regulate the expression of various genes such as: the granulocyte colony stimulating factor, interleukin 3, T cell receptor β and myeloperoxidase (MPO) genes [15]. A high level of expression of RUNX1 is limited to cells of the hematopoietic lineage and to ganglion cells of the developing nervous system. These properties are a result of protein structure encoded by RUNX1 gene. This one has highly homologous to the Drosophila RUNT domain (118 amino acids) at N-terminus which interacts with DNA and CBFβ, however at C-terminus-transactivation domain (TA). The former domain is strictly conserved in fusions proteins coming from the chromosomal changes in which RUNX1 gene participates [1-8].
Breakpoints are scattered throughout the 12 kb intron 5 of ETV6 and the ~100 kb intron 1 on AML1. Statistically, there is some degree of micro clustering, but critically, each patient’s leukemic cells have unique, or clonotypic, breakpoints. The sharing of the same unique clonotypic ETV6/RUNX1 genomic breakpoints and fusion sequences between twins (and that are acquired not constitutive) indicates a single-cell origin. Concordance of disease then arises via spread of clonal progeny from one twin, in which the translocation arises, to the other prenatally via vascular anastomoses within a mono chorionic placenta. These data are endorsed by the detection of putative pre leukemic B-lineage cells in normal cord blood that harbor ETV6/RUNX1 translocations [1-4].
Actually, a greater number of healthy individuals can harbor at some fusion genes as a silent pre-leukemic clone. But Why and/or how? Moreover, these rearrangements could arise in high proportion of developing fetuses, but without any functional chimeric proteins production, also their originate is an inappropriate with cellular context alternatively In other words, in producing a leukemic phenotype, we have two conditions includes 1) Gene fusion structure must permit to functional protein production [2]. The translocation should happen in early precursors with self- renewal ability. So, some researcher stated that in normal individuals, fused genes arise in mature precursors or in differentiated cells which eliminated by cell differentiation normal mechanisms. But how? Or generally, is this right? Also, if somebody believed that the immune system power to recognize and eliminate the cells that express the rearrangement, so why do not ability to the same action in other patients? Some authors suggested that tumor associated translocations in peripheral lymphocytes can be transitory or the rearrangement expressed in hematopoietic cells which entered in the apoptotic pathway, now can be as an irrelevant in mature cells. What does it mean exactly? Also, it is possible that fusion genes associate with previous exposure to diverse exogenous as well as endogenous sources which can consider as the physical and chemical agents in comparing with other cell types [16-19, 27].
But the important question is how infection can lead into leukemic condition? [3, 20] Please look at the figures 2 & 3.
Anyhow, we can say, ETV6/RUNX1 is seen in healthy individuals especially newborns. Therefore, the fusion gene is not sufficient for leukemia development only, so secondary postnatal mutations are necessary (figures 1, 2&3). Some researchers believe that leukemia associated fusion genes before birth. They say, in twins with concordant ETV6/RUNX1 positive leukemia, the development of ALL has been found to occur at different times, and postnatal latency can be variable and occasionally protracted; or somebody say ,ETV6/RUNX1 translocation occurs in utero, followed by pre-leukemic evolution.
The first cells produced, embryonic (or primitive) erythrocytes arise within the blood islands of the yolk sac at embryonic day 14. Later hematopoiesis shifts to the fetal liver and to spleen where adult red cells, as well as cells of other lineages appear- the process of granulo-, mono-lymph- and megakaryocytopoiesis starts. The development ends in bone marrow and in lymphatic nodes. The regulation of these processes takes place at multiple levels to ensure proper blood cells proliferation, differentiation and survival of progenitor’s cells. One of them is operation of cytokines, their receptors and the transcriptional factors, affecting the correct genes expression. Thus, initiation of angiogenesis in the yolk sac, maintenance of life cells, their proper movement from fetal liver and spleen to bone marrow and processes, which work there, are controlled by ETV6 gene. However, ETV6 is not intrinsically required for the growth or differentiation of hematopoietic cells [10-14]. In spite of these facts, the disorder in adhesion and colonization of ETV6-/- HSCs (or progenitors) in microenvironment of bone marrow may reflect the subsequent appearance and circulation in the peripheral blood of premature leukemic progenitors which proliferate excessively. This constitutes a very important element in pathogenesis of ETV6/RUNX1 because the ETV6 loss impairs the progenitor’s capacity for effective hematopoiesis in the boon marrow [12].
Now, the interpretation of figure 1 at after the pre-leukemic condition can be as follows: the action of ETV6/RUNX1 producing a protein that destruct the normal cell and change the HSC to LSC(1st hit) , After the monoclonality stage (clonal expansion) and hyper-proliferation as well which normal cells differentiation is ruined and may be in 2nd hit(chromosomal aberrations, activation of oncogenes, etc.) ,we see the unlimited phase that can be a severely marrow failure or the leukemic cells increased( cancerous stage and/or leukemic evolution). So feedback of this model in leukemic bone marrow niche, HSC maintenance is decreased. In the pathway, BM microenvironment should be disrupted partially or completely and impaired the normal cells production severely [19-22, 24].
Whatever the mechanisms governing chromosomal changes in utero, it is evident that for most cases of childhood leukemia, the crucial etiologic bottleneck is the postnatal ‘promotional’ events or exposures that precipitate the secondary genetic changes, including TEL deletion. In fact, there is a convincing evidence that a significant percentage of the pre-leukemic lesions can arise prenatally and it’s changing in after postnatal secondary occurring process. The first hit occurs in the cell of origin which differs from subtype to subtype, such as ETV6/RUNX1 seem to arise in B cell development (not at earliest stage) but the exact stage of cell is unknown. In this case, infection, delayed infection or other instances are absolutely propounded (figure 1). Also, populations mixing can be as a leukemic transformation factor. But the important factor is infection (figure 3) which can be as a trigger the progression of pre-leukemia to acute leukemia like ALL [20-25].
Now, we want to find that why EBV (Epstein Barr virus) can change to malignancy? In response and in the development of nasopharyngeal carcinoma, a close contact between epithelial cells and B- lymphocytes that may carry EBV genomes, and after EBV induced fusion between the two cell types, now EBV genome enable to enter the epithelial cells(epithelial, EBV). Look at the blocks 1(at cellular level in endogenous block) and block 2(in outside or exogenous block) inhibit the lytic expression of EBV. (Please give attention to figure 1 at pre-leukemic condition and infection role in the matter as well). On the other hand, the clone may lead to the development of BL. We know that block 3 suppresses the proliferation of EBV genome containing lymphoid cells in the periphery. Please look at the pathway of lymphoma in B-cell, EBV(B-lymph- EBV) as well as some factors role like cytogenetic error , unspecific stimulation or clonal selection in changing to lymphoma [19-20, 23-26].
Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.
Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.
Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.
Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.
We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.
The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.
Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.
Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.
Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.
Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.
Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.
This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.
Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.
As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.
Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.
International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.
Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.
Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.
I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!
"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".
I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.
We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.
I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.
I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.
I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.
Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.
“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.
Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.
Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.
Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.
The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.
Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.
Dear Monica Gissare, - Editorial Coordinator of Nutrition and Food Processing. ¨My testimony with you is truly professional, with a positive response regarding the follow-up of the article and its review, you took into account my qualities and the importance of the topic¨.
Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, The review process for the article “The Handling of Anti-aggregants and Anticoagulants in the Oncologic Heart Patient Submitted to Surgery” was extremely rigorous and detailed. From the initial submission to the final acceptance, the editorial team at the “Journal of Clinical Cardiology and Cardiovascular Interventions” demonstrated a high level of professionalism and dedication. The reviewers provided constructive and detailed feedback, which was essential for improving the quality of our work. Communication was always clear and efficient, ensuring that all our questions were promptly addressed. The quality of the “Journal of Clinical Cardiology and Cardiovascular Interventions” is undeniable. It is a peer-reviewed, open-access publication dedicated exclusively to disseminating high-quality research in the field of clinical cardiology and cardiovascular interventions. The journal's impact factor is currently under evaluation, and it is indexed in reputable databases, which further reinforces its credibility and relevance in the scientific field. I highly recommend this journal to researchers looking for a reputable platform to publish their studies.
Dear Editorial Coordinator of the Journal of Nutrition and Food Processing! "I would like to thank the Journal of Nutrition and Food Processing for including and publishing my article. The peer review process was very quick, movement and precise. The Editorial Board has done an extremely conscientious job with much help, valuable comments and advices. I find the journal very valuable from a professional point of view, thank you very much for allowing me to be part of it and I would like to participate in the future!”
Dealing with The Journal of Neurology and Neurological Surgery was very smooth and comprehensive. The office staff took time to address my needs and the response from editors and the office was prompt and fair. I certainly hope to publish with this journal again.Their professionalism is apparent and more than satisfactory. Susan Weiner
My Testimonial Covering as fellowing: Lin-Show Chin. The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews.
My experience publishing in Psychology and Mental Health Care was exceptional. The peer review process was rigorous and constructive, with reviewers providing valuable insights that helped enhance the quality of our work. The editorial team was highly supportive and responsive, making the submission process smooth and efficient. The journal's commitment to high standards and academic rigor makes it a respected platform for quality research. I am grateful for the opportunity to publish in such a reputable journal.
My experience publishing in International Journal of Clinical Case Reports and Reviews was exceptional. I Come forth to Provide a Testimonial Covering the Peer Review Process and the editorial office for the Professional and Impartial Evaluation of the Manuscript.
